Last update Dec. 4, 2020

Phénolphtaléine

Incompatible

Very unsafe. Contraindicated. Use of an alternative or cessation of breastfeeding. Read the Commentary.

Derived from phenol with laxative properties due to direct irritation through contact with the intestinal mucosa.

Since the last update, we have not found published data on its excretion in breastmilk.

Although intestinal absorption is only 15% (PubChem 2017), it may transfer into breastmilk and could cause diarrhoea and other intestinal problems in the infant (PubChem 2017).
Carcinogenic in animals and probable carcinogenic (2B) in humans (WHO 2000, EMA 1997).

It has been withdrawn from sale in most countries.

Bulking, osmotic, emollient, or lubricating laxatives are safer.

In order to avoid or treat constipation, a balanced diet, rich in fibre, is essential,
with plenty of fluids and exercise.

RISK LEVEL OF WORKPLACE EXPOSURE
According to international regulations (INSHT 2017 and 2008, EC Regulation 2008), all potentially polluting or health-damaging products must be labelled with a safety data sheet containing the so-called risk phrases (formerly known as R phrases, currently H phrases for hazard) or prudence (P phrases).
There are two phrases that are specifically related to breastfeeding:
- H362 (formerly R64): "It can harm children fed with breastmilk"
- P263: "Avoid contact during pregnancy and breastfeeding”.

Five other phrases that should be considered during breastfeeding are related to the carcinogenic, mutagenic or cumulative effects of a product:
- H350 (formerly R45 and R49): "May cause cancer"
- H351 (formerly R40): "Possible carcinogenic effects"
- H370 (ant. R39): "Causes damage to organs”
- H371 (ant. R68): "May cause damage to organs”
- H372 (ant R48): "Causes damage to organs through prolonged or repeated exposure”
- H373 (ant. R33): "May cause damage to organs through prolonged or repeated exposure.

If any of these five phrases appears in the safety data sheet of an industrial product, the breastfeeding mother must be removed from her workplace. Phenolphthalein has phrase H350 (Merck 2018).

In addition, according to current European legislation (EC Regulation 2008), when a product is carcinogenic and mutagenic, breastfeeding working mothers should not be exposed to mixtures, be they of solids, liquids or gases, with concentration limits higher than 0.3%.

Alternatives

  • Docusate (Safe substance and/or breastfeeding is the best option.)
  • Lactulose (Safe substance and/or breastfeeding is the best option.)
  • Liquid Paraffin (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Phénolphtaléine is Phenolphthalein in French.

Is written in other languages:

Tradenames

Main tradenames from several countries containing Phénolphtaléine in its composition:

  • Alin
  • Anson™. Contains other elements than Phénolphtaléine in its composition
  • Beagarol™. Contains other elements than Phénolphtaléine in its composition
  • Coslax™. Contains other elements than Phénolphtaléine in its composition
  • Doce Alivio™. Contains other elements than Phénolphtaléine in its composition
  • Emulax™. Contains other elements than Phénolphtaléine in its composition
  • Fenokomp 39™. Contains other elements than Phénolphtaléine in its composition
  • Fructines (Argentina)
  • Genolaxante™. Contains other elements than Phénolphtaléine in its composition
  • Heroanson™. Contains other elements than Phénolphtaléine in its composition
  • Jaglax
  • Laksafenol
  • Laxadine™. Contains other elements than Phénolphtaléine in its composition
  • Oblax A-1-1™. Contains other elements than Phénolphtaléine in its composition
  • Paralax™. Contains other elements than Phénolphtaléine in its composition
  • Taeniacide™. Contains other elements than Phénolphtaléine in its composition
  • Zenda™. Contains other elements than Phénolphtaléine in its composition

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 15 %
Molecular weight 318 daltons

References

  1. INSHT - Instituto Nacional de Seguridad e Higiene en el Trabajo. Límites de exposición profesional para agentes químicos en España. - 2024 Full text (link to original source) Full text (in our servers)
  2. PubChem. Phenolphthalein. Compound Summary. 2017 Full text (link to original source) Full text (in our servers)
  3. INSHT. Listado de compuestos Cancerígenos y Mutágenos categorias 1A y 1B. 2012 Full text (in our servers)
  4. - REGULATION (EC) No 1272/2008 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 16 December 2008 on classification, labelling and packaging of substances and mixtures. Official Journal of the European Union. 2008 Full text (link to original source)
  5. INSHT. Regulación UE sobre productos químicos (II). Reglamento CLP: aspectos básicos. 2008 Full text (in our servers)
  6. . REGLAMENTO (CE) No 1272/2008 DEL PARLAMENTO EUROPEO Y DEL CONSEJO de 16 de diciembre de 2008 sobre clasificación, etiquetado y envasado de sustancias y mezclas. Diario oficial de la Unión Europea. 2008 Full text (link to original source) Full text (in our servers)
  7. WHO. International Agency for research on Cancer. PHENOLPHTHALEIN. Summary of final evaluations. IARC monographs on the evaluation of carcinogenic risks to humans. Vol.76-17. 2000 Full text (link to original source) Full text (in our servers)
  8. WHO. International Agency for research on Cancer. PHENOLPHTHALEIN. IARC monographs on the evaluation of carcinogenic risks to humans. Vol.76-15. 2000 Full text (link to original source) Full text (in our servers)
  9. EMA. Genotoxic and carcinogenic potential of phenolphthalein Position Paper 1997 Full text (link to original source) Full text (in our servers)

Total visits

2,755

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM